Parabilis Medicines, Inc. Unamortized Debt Issuance Expense
Parabilis Medicines, Inc. (PBLS) had Unamortized Debt Issuance Expense of $16.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2026-08-13
- 2026-06-30: Unamortized Debt Issuance Expense $16.00K.
- 2025-12-31: Unamortized Debt Issuance Expense $70.00K.
| Period end | Unamortized Debt Issuance Expense |
|---|---|
| 2026-06-30 | $16.00K 10-Q · filed 2026-08-13 |
| 2025-12-31 | $70.00K 10-Q · filed 2026-08-13 |